نتائج البحث

USE OF AND METHOD FOR TELAPREVIR IN PREPARATION OF DRUG FOR TREATING AN ISCHEMIA/REPERFUSION INJURY AND CYTOPROTECTIVE DRUG

تفاصيل العنوان

Telaprevir in Genotype 3 HCV (TIG3)

• Authors : Janssen-Cilag Ltd.; Barts & The London NHS Trust; St George's Healthcare NHS Trust

• Source: Telaprevir in Patients With Genotype 3 HCV: Pilot Clinical Study to Evaluate Efficacy and Predictability of Therapy in Patients Who Have Failed to Respond to Pegylated

تفاصيل العنوان

The antiviral drug telaprevir induces cell death by reducing FOXA1 expression in estrogen receptor α (ERα)‐positive breast cancer cells

• Authors : Stefania Bartoloni; Stefano Leone; Sara Pescatori

Subjects: breast cancer; estrogen receptor α; FOXA1

• Source: Molecular Oncology, Vol 16, Iss 19, Pp 3568-3584 (2022)

تفاصيل العنوان

The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort

• Authors : Kjellin, Midori; Wesslén, Terése; Löfblad, Erik

Subjects: Boceprevir; hepatitis C; protease inhibitor

• Source: Upsala Journal of Medical Sciences. 123(1):50-56

تفاصيل العنوان

Telaprevirli Üçlü Tedavi Alan 53 Kronik Hepatit C Olgusunun Değerlendirilmesi.

• Authors : Şahin, Ahmet¹ ; Bayram, Halim²; Namıduru, Mustafa³

• Source: Klimik Journal / Klimik Dergisi. ara2017, Vol. 30 Issue 3, p126-130. 5p.

تفاصيل العنوان

Integrated quality by design (QbD) and design of experiments (DoE) approach for UFLC determination of telaprevir in rat serum.

• Authors : Panda, Sagar Suman¹ (AUTHOR) ; Sharma, Khusbu¹ (AUTHOR); Mohanty, Bijeta¹ (AUTHOR)

Subjects: *PICOSECOND pulses; *LIQUID chromatography; *TELAPREVIR

• Source: Journal of Liquid Chromatography & Related Technologies. 2017, Vol. 40 Issue 19, p951-958. 8p. 2 Diagrams, 4 Charts, 4 Graphs.

تفاصيل العنوان

A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response

• Authors : Tibotec Pharmaceutical Limited

• Source: A Randomized Study of Stopping Treatment at 24 Weeks or Continuing Treatment to 48 Weeks in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response

تفاصيل العنوان

Interaction Between Paroxetine and Telaprevir (ROLEX)

• Authors : Janssen, LP

• Source: The ROLE of ParoXetine in Patients Taking Telaprevir-based Hepatitis C Therapy: Lack of a Drug-drug Interaction? (ROLEX)

تفاصيل العنوان

DESIGN AND DEVELOPMENT OF SPRAY DRIED TELAPREVIR FOR IMPROVING THE DISSOLUTION FROM TABLETS.

• Authors : Guntaka, Purna Chandra Reddy¹; Lankalapalli, Srinivas¹

• Source: International Journal of Pharmaceutical, Chemical & Biological Sciences. Oct-Dec2017, Vol. 7 Issue 4, p430-438. 9p.

تفاصيل العنوان

Efficacy and safety profile of boceprevir- or telaprevir-based triple therapy or dual peginterferon alfa-2a or alfa-2b plus ribavirin therapy in chronic hepatitis C: the real-world PegBase observational study.

• Authors : Mangia, Alessandra¹ ; Foster, Graham R.²; Berg, Christoph P.³

• Source: Annals of Gastroenterology. 2017, Vol. 30 Issue 3, p327-343. 17p.

تفاصيل العنوان